Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro.

× No keyword cloud information.

23 in total

1. Inhibition of replication of hepatitis B virus by cytallene in vitro.

Authors: Y L Zhu; S B Pai; S H Liu; K L Grove; B C Jones; C Simons; J Zemlicka; Y C Cheng
Journal: Antimicrob Agents Chemother Date: 1997-08 Impact factor: 5.191

2. Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog.

Authors: Elijah Paintsil; Ginger E Dutschman; Rong Hu; Susan P Grill; Wing Lam; Masanori Baba; Hiromichi Tanaka; Yung-Chi Cheng
Journal: Antimicrob Agents Chemother Date: 2007-08-27 Impact factor: 5.191

3. Unique metabolism of a novel antiviral L-nucleoside analog, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil: a substrate for both thymidine kinase and deoxycytidine kinase.

Authors: S H Liu; K L Grove; Y C Cheng
Journal: Antimicrob Agents Chemother Date: 1998-04 Impact factor: 5.191

4. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.

Authors: F Le Guerhier; C Pichoud; C Jamard; S Guerret; M Chevallier; S Peyrol; O Hantz; I King; C Trépo; Y C Cheng; F Zoulim
Journal: Antimicrob Agents Chemother Date: 2001-04 Impact factor: 5.191

5. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.

Authors: E Matthes; A Funk; I Krahn; K Gaertner; M von Janta-Lipinski; L Lin; H Will; H Sirma
Journal: Antimicrob Agents Chemother Date: 2007-04-02 Impact factor: 5.191

6. Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity.

Authors: L Placidi; E Cretton-Scott; G Gosselin; C Pierra; R F Schinazi; J L Imbach; M H el Kouni; J P Sommadossi
Journal: Antimicrob Agents Chemother Date: 2000-04 Impact factor: 5.191

7. In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.

Authors: Jennifer L Hammond; Urvi M Parikh; Dianna L Koontz; Susan Schlueter-Wirtz; Chung K Chu; Hengameh Z Bazmi; Raymond F Schinazi; John W Mellors
Journal: Antimicrob Agents Chemother Date: 2005-09 Impact factor: 5.191

8. Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity.

Authors: Ginger E Dutschman; Susan P Grill; Elizabeth A Gullen; Kazuhiro Haraguchi; Shingo Takeda; Hiromichi Tanaka; Masanori Baba; Yung-Chi Cheng
Journal: Antimicrob Agents Chemother Date: 2004-05 Impact factor: 5.191

9. Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells.

Authors: Lin-Lin Gao; Xiao-Yan Wang; Ju-Sheng Lin; Ying-Hui Zhang; Yan Li
Journal: World J Gastroenterol Date: 2008-02-28 Impact factor: 5.742

Review 10. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors: Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal: Nat Rev Drug Discov Date: 2013-06 Impact factor: 84.694